Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2026)
Kiniksa Pharmaceuticals International's Gross Profit came in at $220.03 million for Q2 2026, up 59.2% from $138.19 million a year earlier and up 13.7% from the prior quarter.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Gross Profit (2021 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Kiniksa Pharmaceuticals International reported Gross Profit of $755.28 million, up 66.0% year-over-year; for FY2025, it came in at $599.89 million, up 65.6% from FY2024.
- Gross Profit has increased in each of the last four years, with a four-year compound annual growth rate of 112.5% (FY2021 to FY2025).
- Going back by year, Gross Profit was $362.33 million in FY2024 (+53.0%), $236.85 million in FY2023 (+20.1%), $197.29 million in FY2022 (+570.0%) and $29.44 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q2 2021.
- Year-over-year, Gross Profit has increased for 11 consecutive quarters, with growth averaging 60.7% over the last eight quarters.
- The fastest year-over-year change in Gross Profit over five years came in Q3 2022 (growth of 888.4%), and the weakest in Q3 2023 (a decline of 37.1%).
- Business Quant data shows KNSA's Gross Profit at $193.47 million (Q1 2026), $181.18 million (Q4 2025) and $160.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 220.03 Mn |
| Mar 31, 2026 | 193.47 Mn |
| Dec 31, 2025 | 181.18 Mn |
| Sep 30, 2025 | 160.60 Mn |
| Jun 30, 2025 | 138.19 Mn |
| Mar 31, 2025 | 119.92 Mn |
| Dec 31, 2024 | 104.64 Mn |
| Sep 30, 2024 | 92.11 Mn |
| Jun 30, 2024 | 96.31 Mn |
| Mar 31, 2024 | 69.28 Mn |
| Dec 31, 2023 | 73.81 Mn |
| Sep 30, 2023 | 57.96 Mn |
| Jun 30, 2023 | 63.77 Mn |
| Mar 31, 2023 | 41.31 Mn |
| Dec 31, 2022 | 55.17 Mn |
| Sep 30, 2022 | 92.20 Mn |
| Jun 30, 2022 | 21.94 Mn |
| Mar 31, 2022 | 27.97 Mn |
| Dec 31, 2021 | 14.88 Mn |
| Sep 30, 2021 | 9.33 Mn |
API Access
Kiniksa Pharmaceuticals International Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();